

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | very-low-density lipoprotein particle assembly (GO:0034379) | 7.68002818 |
| 2 | plasma lipoprotein particle assembly (GO:0034377) | 7.30801705 |
| 3 | desmosome organization (GO:0002934) | 6.63264625 |
| 4 | protein-lipid complex assembly (GO:0065005) | 6.53382903 |
| 5 | regulation of water loss via skin (GO:0033561) | 6.24026027 |
| 6 | establishment of skin barrier (GO:0061436) | 6.21010841 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.15488991 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 6.09362570 |
| 9 | regulation of bile acid biosynthetic process (GO:0070857) | 6.01172952 |
| 10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.81130817 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.79919815 |
| 12 | lipoprotein transport (GO:0042953) | 5.75624840 |
| 13 | hemidesmosome assembly (GO:0031581) | 5.65869488 |
| 14 | protein-lipid complex remodeling (GO:0034368) | 5.44425419 |
| 15 | macromolecular complex remodeling (GO:0034367) | 5.44425419 |
| 16 | plasma lipoprotein particle remodeling (GO:0034369) | 5.44425419 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43713943 |
| 18 | cholesterol efflux (GO:0033344) | 5.31515940 |
| 19 | diacylglycerol metabolic process (GO:0046339) | 5.31447841 |
| 20 | plasma lipoprotein particle organization (GO:0071827) | 5.23784804 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.03980000 |
| 22 | NADH metabolic process (GO:0006734) | 5.02042883 |
| 23 | low-density lipoprotein particle remodeling (GO:0034374) | 4.96116607 |
| 24 | protein-lipid complex subunit organization (GO:0071825) | 4.94102846 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.92403437 |
| 26 | reverse cholesterol transport (GO:0043691) | 4.89954767 |
| 27 | multicellular organismal water homeostasis (GO:0050891) | 4.87141897 |
| 28 | fructose metabolic process (GO:0006000) | 4.77049738 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.75818241 |
| 30 | lipoprotein metabolic process (GO:0042157) | 4.72907279 |
| 31 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.59398144 |
| 32 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.59398144 |
| 33 | keratinization (GO:0031424) | 4.50845564 |
| 34 | regulation of guanylate cyclase activity (GO:0031282) | 4.45965911 |
| 35 | renal absorption (GO:0070293) | 4.45059960 |
| 36 | drug transmembrane transport (GO:0006855) | 4.43441996 |
| 37 | peptide catabolic process (GO:0043171) | 4.43271851 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.43247345 |
| 39 | drug metabolic process (GO:0017144) | 4.41779852 |
| 40 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.40020832 |
| 41 | endocrine process (GO:0050886) | 4.40020832 |
| 42 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.40020832 |
| 43 | regulation of fibrinolysis (GO:0051917) | 4.39392897 |
| 44 | angiotensin maturation (GO:0002003) | 4.36494549 |
| 45 | regulation of complement activation (GO:0030449) | 4.32180665 |
| 46 | intestinal absorption (GO:0050892) | 4.32057460 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 4.25791837 |
| 48 | phospholipid scrambling (GO:0017121) | 4.25546548 |
| 49 | detection of bacterium (GO:0016045) | 4.16514057 |
| 50 | excretion (GO:0007588) | 4.10381989 |
| 51 | protein carboxylation (GO:0018214) | 4.10196708 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.10196708 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.09880757 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.09880757 |
| 55 | surfactant homeostasis (GO:0043129) | 4.07808796 |
| 56 | one-carbon compound transport (GO:0019755) | 4.06790896 |
| 57 | urea metabolic process (GO:0019627) | 4.06776513 |
| 58 | cellular glucuronidation (GO:0052695) | 4.05127562 |
| 59 | cholesterol homeostasis (GO:0042632) | 4.05120037 |
| 60 | drug transport (GO:0015893) | 4.02589026 |
| 61 | proline metabolic process (GO:0006560) | 4.00585175 |
| 62 | sterol homeostasis (GO:0055092) | 3.99003707 |
| 63 | water homeostasis (GO:0030104) | 3.98673859 |
| 64 | urea cycle (GO:0000050) | 3.98436190 |
| 65 | virion attachment to host cell (GO:0019062) | 3.95773472 |
| 66 | adhesion of symbiont to host cell (GO:0044650) | 3.95773472 |
| 67 | uronic acid metabolic process (GO:0006063) | 3.94320601 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.94320601 |
| 69 | response to phenylpropanoid (GO:0080184) | 3.91195206 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.87728090 |
| 71 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.84174334 |
| 72 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.82791536 |
| 73 | urate metabolic process (GO:0046415) | 3.77126542 |
| 74 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.77040881 |
| 75 | vitamin transmembrane transport (GO:0035461) | 3.75937337 |
| 76 | regulation of systemic arterial blood pressure (GO:0003073) | 3.75927417 |
| 77 | bile acid and bile salt transport (GO:0015721) | 3.75067859 |
| 78 | keratinocyte differentiation (GO:0030216) | 3.72812322 |
| 79 | exogenous drug catabolic process (GO:0042738) | 3.72596914 |
| 80 | L-ascorbic acid metabolic process (GO:0019852) | 3.70101370 |
| 81 | sphingoid metabolic process (GO:0046519) | 3.69148894 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 3.68983551 |
| 83 | interferon-gamma secretion (GO:0072643) | 3.67176466 |
| 84 | bile acid metabolic process (GO:0008206) | 3.65707521 |
| 85 | hormone catabolic process (GO:0042447) | 3.65109920 |
| 86 | detection of other organism (GO:0098543) | 3.64728625 |
| 87 | chemical homeostasis within a tissue (GO:0048875) | 3.60523889 |
| 88 | glutathione biosynthetic process (GO:0006750) | 3.58831554 |
| 89 | polyol transport (GO:0015791) | 3.56539473 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 3.53079120 |
| 91 | drinking behavior (GO:0042756) | 3.51255696 |
| 92 | regulation of apoptotic cell clearance (GO:2000425) | 3.50407520 |
| 93 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.48746592 |
| 94 | transepithelial transport (GO:0070633) | 3.48660982 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.46502845 |
| 96 | intermediate filament organization (GO:0045109) | 3.43112903 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.42405227 |
| 98 | drug catabolic process (GO:0042737) | 3.37107414 |
| 99 | regulation of ruffle assembly (GO:1900027) | 3.36988617 |
| 100 | complement activation, alternative pathway (GO:0006957) | 3.36297580 |
| 101 | regulation of natural killer cell differentiation (GO:0032823) | 3.32975250 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.31848473 |
| 103 | L-phenylalanine catabolic process (GO:0006559) | 3.31848473 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.31460255 |
| 105 | negative regulation of hemostasis (GO:1900047) | 3.29491295 |
| 106 | negative regulation of blood coagulation (GO:0030195) | 3.29491295 |
| 107 | diol metabolic process (GO:0034311) | 3.29388885 |
| 108 | intestinal cholesterol absorption (GO:0030299) | 3.29048157 |
| 109 | modified amino acid transport (GO:0072337) | 3.28886589 |
| 110 | acylglycerol homeostasis (GO:0055090) | 3.28565933 |
| 111 | triglyceride homeostasis (GO:0070328) | 3.28565933 |
| 112 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.26406241 |
| 113 | regulation of cholesterol metabolic process (GO:0090181) | 3.26340515 |
| 114 | beta-amyloid metabolic process (GO:0050435) | 3.26024077 |
| 115 | proline biosynthetic process (GO:0006561) | 3.23288773 |
| 116 | organic cation transport (GO:0015695) | 3.22859015 |
| 117 | sphingosine metabolic process (GO:0006670) | 3.21189751 |
| 118 | glutathione derivative biosynthetic process (GO:1901687) | 3.20810062 |
| 119 | glutathione derivative metabolic process (GO:1901685) | 3.20810062 |
| 120 | renal system process involved in regulation of blood volume (GO:0001977) | 3.20470472 |
| 121 | lysine catabolic process (GO:0006554) | 3.19694753 |
| 122 | lysine metabolic process (GO:0006553) | 3.19694753 |
| 123 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.19398750 |
| 124 | ethanol metabolic process (GO:0006067) | 3.18835900 |
| 125 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.18322494 |
| 126 | L-phenylalanine metabolic process (GO:0006558) | 3.18322494 |
| 127 | phosphate ion transport (GO:0006817) | 3.17472344 |
| 128 | epidermal cell differentiation (GO:0009913) | 3.16918877 |
| 129 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.14824599 |
| 130 | lipid homeostasis (GO:0055088) | 3.13871610 |
| 131 | cholesterol transport (GO:0030301) | 3.12683551 |
| 132 | sterol transport (GO:0015918) | 3.12683551 |
| 133 | hydrogen peroxide catabolic process (GO:0042744) | 3.11643217 |
| 134 | positive regulation of steroid metabolic process (GO:0045940) | 3.10380370 |
| 135 | peptide hormone processing (GO:0016486) | 3.10118252 |
| 136 | complement activation, classical pathway (GO:0006958) | 3.09773903 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08808576 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08808576 |
| 139 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.08244714 |
| 140 | vitamin biosynthetic process (GO:0009110) | 3.06114569 |
| 141 | negative regulation of coagulation (GO:0050819) | 3.05923032 |
| 142 | adhesion of symbiont to host (GO:0044406) | 3.04315551 |
| 143 | intestinal epithelial cell development (GO:0060576) | 2.96761499 |
| 144 | keratinocyte proliferation (GO:0043616) | 2.94923023 |
| 145 | flavonoid metabolic process (GO:0009812) | 2.92533023 |
| 146 | peptide cross-linking (GO:0018149) | 2.92391194 |
| 147 | growth hormone receptor signaling pathway (GO:0060396) | 2.91215525 |
| 148 | innate immune response in mucosa (GO:0002227) | 2.90298778 |
| 149 | phosphate ion transmembrane transport (GO:0035435) | 2.84030277 |
| 150 | antibacterial humoral response (GO:0019731) | 2.82488432 |
| 151 | positive regulation of hair follicle development (GO:0051798) | 2.81341501 |
| 152 | positive regulation of hair cycle (GO:0042635) | 2.81341501 |
| 153 | cellular response to vitamin D (GO:0071305) | 2.81208320 |
| 154 | gas transport (GO:0015669) | 2.78918183 |
| 155 | tight junction assembly (GO:0070830) | 2.78195662 |
| 156 | peptide biosynthetic process (GO:0043043) | 2.77014982 |
| 157 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76433881 |
| 158 | thyroid hormone metabolic process (GO:0042403) | 2.75924394 |
| 159 | epithelial cell-cell adhesion (GO:0090136) | 2.75883539 |
| 160 | vitamin A metabolic process (GO:0006776) | 2.75754459 |
| 161 | positive regulation of epidermis development (GO:0045684) | 2.72257302 |
| 162 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.70462098 |
| 163 | cysteine metabolic process (GO:0006534) | 2.69865162 |
| 164 | antimicrobial humoral response (GO:0019730) | 2.68468706 |
| 165 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.68289338 |
| 166 | ethanol oxidation (GO:0006069) | 2.65080052 |
| 167 | ectoderm development (GO:0007398) | 2.64952487 |
| 168 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.64523328 |
| 169 | epidermis development (GO:0008544) | 2.64334537 |
| 170 | toxin transport (GO:1901998) | 2.62871064 |
| 171 | organ or tissue specific immune response (GO:0002251) | 2.62628224 |
| 172 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.60965631 |
| 173 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.60004524 |
| 174 | digestive system process (GO:0022600) | 2.59396210 |
| 175 | phosphate ion homeostasis (GO:0055062) | 2.58683813 |
| 176 | trivalent inorganic anion homeostasis (GO:0072506) | 2.58683813 |
| 177 | xenobiotic catabolic process (GO:0042178) | 2.58458964 |
| 178 | actin filament depolymerization (GO:0030042) | 2.58377645 |
| 179 | phospholipid efflux (GO:0033700) | 2.55572631 |
| 180 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.54182107 |
| 181 | O-glycan processing (GO:0016266) | 2.52862565 |
| 182 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.51287530 |
| 183 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.51287530 |
| 184 | mucosal immune response (GO:0002385) | 2.50582233 |
| 185 | sulfur compound transport (GO:0072348) | 2.50553275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.26399615 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.28926344 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.27924081 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.99600243 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.65977690 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.61890846 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.59672085 |
| 8 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.50056949 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27275925 |
| 10 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.26384354 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.21799058 |
| 12 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.19681735 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.18684797 |
| 14 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.11520281 |
| 15 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.04391072 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.00500814 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.3345067 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99929978 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93073598 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90051769 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.89765575 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83962781 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.83501529 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77326059 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.77048501 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74768241 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.72266414 |
| 28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70808803 |
| 29 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.69547699 |
| 30 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.69547699 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.68349396 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67592612 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67018031 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66163029 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65439692 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64373482 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60579075 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54840868 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53526037 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53162631 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53061204 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.50720042 |
| 43 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.48717378 |
| 44 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47124633 |
| 45 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46769825 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42767381 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42115143 |
| 48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40400143 |
| 49 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39496494 |
| 50 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.35573122 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33941152 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32270460 |
| 53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25977706 |
| 54 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23066265 |
| 55 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22991872 |
| 56 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.21482780 |
| 57 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20699327 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20225999 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19968019 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19129713 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13632301 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13389561 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10837330 |
| 64 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.09130371 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08955221 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07965472 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07235304 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05458007 |
| 69 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03122703 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03067892 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.00797379 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00436034 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99509677 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98656175 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97081059 |
| 76 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96749414 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96663818 |
| 78 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94901340 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94267922 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92480272 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91640102 |
| 82 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90787567 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90613059 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.90206811 |
| 85 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89766920 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89394040 |
| 87 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89152916 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89016420 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87208974 |
| 90 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86047756 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85814234 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85760621 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84957252 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84957252 |
| 95 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84567356 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84422876 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83449945 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.82780766 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81342270 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81269219 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80306616 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79918527 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79019596 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78757580 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78597314 |
| 106 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78254387 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78089551 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78043319 |
| 109 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77832968 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77607855 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76669515 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76573090 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75440094 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75270309 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74707834 |
| 116 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74216840 |
| 117 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73198095 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72993534 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72854192 |
| 120 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.72668374 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70817701 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70289330 |
| 123 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68975570 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68448965 |
| 125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.67987563 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.67601557 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.67588567 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67547502 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.67369123 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66315926 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.65015700 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64505019 |
| 133 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.64282586 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.63823638 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.63642995 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63145692 |
| 137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.63094862 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.62967851 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.62704562 |
| 140 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.62442779 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.62327753 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61334652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.52538858 |
| 2 | MP0002254_reproductive_system_inflammat | 5.13662511 |
| 3 | MP0002796_impaired_skin_barrier | 4.83485880 |
| 4 | MP0005360_urolithiasis | 4.32535803 |
| 5 | MP0009840_abnormal_foam_cell | 3.95260758 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.05746599 |
| 7 | MP0005501_abnormal_skin_physiology | 2.98813605 |
| 8 | MP0003941_abnormal_skin_development | 2.89584828 |
| 9 | MP0010678_abnormal_skin_adnexa | 2.85835503 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.66097319 |
| 11 | MP0005451_abnormal_body_composition | 2.54770702 |
| 12 | MP0002098_abnormal_vibrissa_morphology | 2.51100880 |
| 13 | MP0003868_abnormal_feces_composition | 2.47287027 |
| 14 | MP0004381_abnormal_hair_follicle | 2.38949590 |
| 15 | MP0000579_abnormal_nail_morphology | 2.27587051 |
| 16 | MP0004043_abnormal_pH_regulation | 2.24154319 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.24139232 |
| 18 | MP0003453_abnormal_keratinocyte_physiol | 2.20204041 |
| 19 | MP0001216_abnormal_epidermal_layer | 2.15390838 |
| 20 | MP0004947_skin_inflammation | 2.15029116 |
| 21 | MP0005409_darkened_coat_color | 2.14299544 |
| 22 | MP0000383_abnormal_hair_follicle | 2.11592811 |
| 23 | MP0005275_abnormal_skin_tensile | 2.09395814 |
| 24 | MP0002060_abnormal_skin_morphology | 2.02240217 |
| 25 | MP0001346_abnormal_lacrimal_gland | 1.94042984 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89249215 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.87977439 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.80076045 |
| 29 | MP0000538_abnormal_urinary_bladder | 1.78299264 |
| 30 | MP0010771_integument_phenotype | 1.77010717 |
| 31 | MP0005670_abnormal_white_adipose | 1.73570583 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.72923604 |
| 33 | MP0000377_abnormal_hair_follicle | 1.72157301 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.70829632 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.61402886 |
| 36 | MP0000609_abnormal_liver_physiology | 1.60274172 |
| 37 | MP0001849_ear_inflammation | 1.60055094 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.58782094 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.55442661 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.55093497 |
| 41 | MP0003878_abnormal_ear_physiology | 1.55093497 |
| 42 | MP0001873_stomach_inflammation | 1.52906715 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.52766820 |
| 44 | MP0001764_abnormal_homeostasis | 1.51986064 |
| 45 | MP0006054_spinal_hemorrhage | 1.45669152 |
| 46 | MP0003122_maternal_imprinting | 1.43817971 |
| 47 | MP0002136_abnormal_kidney_physiology | 1.42547517 |
| 48 | MP0000467_abnormal_esophagus_morphology | 1.42533758 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.39834407 |
| 50 | MP0005310_abnormal_salivary_gland | 1.37512184 |
| 51 | MP0005332_abnormal_amino_acid | 1.36113984 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.35761261 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.34889788 |
| 54 | MP0003879_abnormal_hair_cell | 1.34278215 |
| 55 | MP0002009_preneoplasia | 1.34172730 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.31826038 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.30237457 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.30077475 |
| 59 | MP0000566_synostosis | 1.29219474 |
| 60 | MP0003195_calcinosis | 1.27300345 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.25741435 |
| 62 | MP0003252_abnormal_bile_duct | 1.25508969 |
| 63 | MP0000427_abnormal_hair_cycle | 1.21349601 |
| 64 | MP0003866_abnormal_defecation | 1.12659823 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.11125953 |
| 66 | MP0001756_abnormal_urination | 1.09673804 |
| 67 | MP0005408_hypopigmentation | 1.09527498 |
| 68 | MP0001191_abnormal_skin_condition | 1.09004463 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.08386631 |
| 70 | MP0003718_maternal_effect | 1.08353118 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.06881437 |
| 72 | MP0001881_abnormal_mammary_gland | 1.05716106 |
| 73 | MP0000462_abnormal_digestive_system | 1.04779316 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.01939394 |
| 75 | MP0002971_abnormal_brown_adipose | 1.01815855 |
| 76 | MP0002089_abnormal_postnatal_growth/wei | 1.01254134 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.98157648 |
| 78 | MP0005448_abnormal_energy_balance | 0.97960943 |
| 79 | MP0009115_abnormal_fat_cell | 0.96530946 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.96500124 |
| 81 | MP0009931_abnormal_skin_appearance | 0.94400333 |
| 82 | MP0002132_abnormal_respiratory_system | 0.92297992 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.92192163 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90204595 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.89978608 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.87662989 |
| 87 | MP0000685_abnormal_immune_system | 0.87331605 |
| 88 | MP0000627_abnormal_mammary_gland | 0.86993073 |
| 89 | MP0000647_abnormal_sebaceous_gland | 0.86617973 |
| 90 | MP0004270_analgesia | 0.83134775 |
| 91 | MP0000604_amyloidosis | 0.83091626 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.81526573 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.80972983 |
| 94 | MP0005365_abnormal_bile_salt | 0.80946740 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.79516883 |
| 96 | MP0000613_abnormal_salivary_gland | 0.78710556 |
| 97 | MP0000367_abnormal_coat/_hair | 0.77920473 |
| 98 | MP0005166_decreased_susceptibility_to | 0.76030103 |
| 99 | MP0008469_abnormal_protein_level | 0.74956876 |
| 100 | MP0001663_abnormal_digestive_system | 0.74349564 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.72942785 |
| 102 | MP0000598_abnormal_liver_morphology | 0.72282839 |
| 103 | MP0005410_abnormal_fertilization | 0.72165779 |
| 104 | MP0002006_tumorigenesis | 0.71069606 |
| 105 | MP0004858_abnormal_nervous_system | 0.69713666 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.69033353 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.68941331 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.68664669 |
| 109 | MP0000516_abnormal_urinary_system | 0.68664669 |
| 110 | MP0001664_abnormal_digestion | 0.68516421 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.68119727 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.67964495 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.67626101 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.65091758 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.64817626 |
| 116 | MP0004885_abnormal_endolymph | 0.63722688 |
| 117 | MP0003045_fibrosis | 0.63174246 |
| 118 | MP0006082_CNS_inflammation | 0.62993501 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.62652374 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.62585180 |
| 121 | MP0000249_abnormal_blood_vessel | 0.62558862 |
| 122 | MP0008004_abnormal_stomach_pH | 0.62428194 |
| 123 | MP0005535_abnormal_body_temperature | 0.61183051 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.60294063 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.58513372 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.58406034 |
| 127 | MP0005023_abnormal_wound_healing | 0.58269298 |
| 128 | MP0008260_abnormal_autophagy | 0.57347230 |
| 129 | MP0003329_amyloid_beta_deposits | 0.56605477 |
| 130 | MP0009785_altered_susceptibility_to | 0.56047788 |
| 131 | MP0004147_increased_porphyrin_level | 0.55063156 |
| 132 | MP0005334_abnormal_fat_pad | 0.54461986 |
| 133 | MP0003953_abnormal_hormone_level | 0.53385396 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.52952646 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.52867692 |
| 136 | MP0004272_abnormal_basement_membrane | 0.52431366 |
| 137 | MP0009764_decreased_sensitivity_to | 0.52110451 |
| 138 | MP0000490_abnormal_crypts_of | 0.52016823 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.51896540 |
| 140 | MP0005395_other_phenotype | 0.51041146 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.50940754 |
| 142 | MP0000470_abnormal_stomach_morphology | 0.50938718 |
| 143 | MP0001851_eye_inflammation | 0.50599938 |
| 144 | MP0009697_abnormal_copulation | 0.49002401 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.46782752 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.45572142 |
| 147 | MP0003436_decreased_susceptibility_to | 0.45491895 |
| 148 | MP0003123_paternal_imprinting | 0.41655374 |
| 149 | MP0001188_hyperpigmentation | 0.39282837 |
| 150 | MP0001915_intracranial_hemorrhage | 0.38773894 |
| 151 | MP0006138_congestive_heart_failure | 0.38745591 |
| 152 | MP0005257_abnormal_intraocular_pressure | 0.38744710 |
| 153 | MP0002135_abnormal_kidney_morphology | 0.36853523 |
| 154 | MP0002909_abnormal_adrenal_gland | 0.34908071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.66891629 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.90959143 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.78752873 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.36306594 |
| 5 | Complement deficiency (HP:0004431) | 5.05216546 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 4.91275838 |
| 7 | Xanthomatosis (HP:0000991) | 4.90352007 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.82142357 |
| 9 | Acanthocytosis (HP:0001927) | 4.78121954 |
| 10 | Increased IgE level (HP:0003212) | 4.65790287 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.60948894 |
| 12 | Onycholysis (HP:0001806) | 4.57855453 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.54360949 |
| 14 | Abnormality of chloride homeostasis (HP:0011422) | 4.48788222 |
| 15 | Abnormality of nail color (HP:0100643) | 4.41469337 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.35055741 |
| 17 | Glomerulonephritis (HP:0000099) | 4.28608274 |
| 18 | Metabolic alkalosis (HP:0200114) | 4.28460350 |
| 19 | Fat malabsorption (HP:0002630) | 4.28128121 |
| 20 | Milia (HP:0001056) | 4.15881205 |
| 21 | Plantar hyperkeratosis (HP:0007556) | 4.15289733 |
| 22 | Abnormality of complement system (HP:0005339) | 4.11473296 |
| 23 | Hemorrhage of the eye (HP:0011885) | 4.08955069 |
| 24 | Joint hemorrhage (HP:0005261) | 4.06291859 |
| 25 | Lip pit (HP:0100267) | 3.98517761 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.97108971 |
| 27 | Gout (HP:0001997) | 3.89782635 |
| 28 | Hypokalemic alkalosis (HP:0001949) | 3.87869970 |
| 29 | Increased circulating renin level (HP:0000848) | 3.86766768 |
| 30 | Pili torti (HP:0003777) | 3.82165430 |
| 31 | Dehydration (HP:0001944) | 3.76889495 |
| 32 | Abnormality of renal excretion (HP:0011036) | 3.73890254 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 3.69629305 |
| 34 | Hydroxyprolinuria (HP:0003080) | 3.69629305 |
| 35 | Woolly hair (HP:0002224) | 3.57388907 |
| 36 | Fragile nails (HP:0001808) | 3.52033773 |
| 37 | Pigmentary retinal degeneration (HP:0001146) | 3.51824065 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.48390477 |
| 39 | Hypomagnesemia (HP:0002917) | 3.47940868 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.46995805 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46995805 |
| 42 | Abnormal urine output (HP:0012590) | 3.37119899 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 3.32105346 |
| 44 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.29803718 |
| 45 | Palmoplantar hyperkeratosis (HP:0000972) | 3.29630344 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.20478212 |
| 47 | Natal tooth (HP:0000695) | 3.20462307 |
| 48 | Confusion (HP:0001289) | 3.20259403 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.14533564 |
| 50 | Polyuria (HP:0000103) | 3.12399230 |
| 51 | Tetany (HP:0001281) | 3.10804996 |
| 52 | Abnormality of vitamin metabolism (HP:0100508) | 3.10735094 |
| 53 | Wide cranial sutures (HP:0010537) | 3.10667132 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 3.07640907 |
| 55 | Hyperuricemia (HP:0002149) | 3.05197841 |
| 56 | Increased purine levels (HP:0004368) | 3.05197841 |
| 57 | Palmar hyperkeratosis (HP:0010765) | 3.05141408 |
| 58 | Abnormality of vitamin B metabolism (HP:0004340) | 3.04969314 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 3.00702122 |
| 60 | Advanced eruption of teeth (HP:0006288) | 2.99003818 |
| 61 | Renal salt wasting (HP:0000127) | 2.97858304 |
| 62 | Abnormality of magnesium homeostasis (HP:0004921) | 2.94283922 |
| 63 | Chronic diarrhea (HP:0002028) | 2.91394924 |
| 64 | Hyperaldosteronism (HP:0000859) | 2.89082133 |
| 65 | Hypoplasia of dental enamel (HP:0006297) | 2.87256242 |
| 66 | Atrophic scars (HP:0001075) | 2.83411970 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.82397154 |
| 68 | Curly hair (HP:0002212) | 2.80760137 |
| 69 | Malnutrition (HP:0004395) | 2.79694909 |
| 70 | Nephritis (HP:0000123) | 2.79496657 |
| 71 | Abnormality of the gastric mucosa (HP:0004295) | 2.79362904 |
| 72 | Nausea (HP:0002018) | 2.78833781 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.78647200 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.78284917 |
| 75 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.73773675 |
| 76 | Villous atrophy (HP:0011473) | 2.73773675 |
| 77 | Hypophosphatemic rickets (HP:0004912) | 2.71241152 |
| 78 | Abnormal blistering of the skin (HP:0008066) | 2.65720582 |
| 79 | Renal tubular acidosis (HP:0001947) | 2.63176276 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.61297768 |
| 81 | Hyperglycinuria (HP:0003108) | 2.61175120 |
| 82 | Steatorrhea (HP:0002570) | 2.58354364 |
| 83 | Nail dystrophy (HP:0008404) | 2.55731465 |
| 84 | Pustule (HP:0200039) | 2.55395412 |
| 85 | Hypophosphatemia (HP:0002148) | 2.54587795 |
| 86 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.52328853 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 2.51237385 |
| 88 | Ectropion (HP:0000656) | 2.48638005 |
| 89 | Spontaneous abortion (HP:0005268) | 2.47780884 |
| 90 | Vascular calcification (HP:0004934) | 2.45250133 |
| 91 | Hyperammonemia (HP:0001987) | 2.44377458 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 2.44349193 |
| 93 | Ileus (HP:0002595) | 2.41320873 |
| 94 | Hyperlipoproteinemia (HP:0010980) | 2.39910259 |
| 95 | Poikilocytosis (HP:0004447) | 2.39042946 |
| 96 | Nephrolithiasis (HP:0000787) | 2.38998755 |
| 97 | Abnormal drinking behavior (HP:0030082) | 2.33300908 |
| 98 | Polydipsia (HP:0001959) | 2.33300908 |
| 99 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29067561 |
| 100 | Hypotension (HP:0002615) | 2.28997600 |
| 101 | Alkalosis (HP:0001948) | 2.27600472 |
| 102 | Abnormal urine phosphate concentration (HP:0012599) | 2.26979000 |
| 103 | Widely patent fontanelles and sutures (HP:0004492) | 2.25708975 |
| 104 | Hypoalphalipoproteinemia (HP:0003233) | 2.25549749 |
| 105 | Menorrhagia (HP:0000132) | 2.23963868 |
| 106 | Osteomalacia (HP:0002749) | 2.22836074 |
| 107 | Gingival bleeding (HP:0000225) | 2.20925584 |
| 108 | Skin nodule (HP:0200036) | 2.20376967 |
| 109 | Cardiovascular calcification (HP:0011915) | 2.19650151 |
| 110 | Hypokalemia (HP:0002900) | 2.18578444 |
| 111 | Hypercalciuria (HP:0002150) | 2.15154960 |
| 112 | Erythroderma (HP:0001019) | 2.14609766 |
| 113 | Corneal erosion (HP:0200020) | 2.14444099 |
| 114 | Pruritus (HP:0000989) | 2.12173094 |
| 115 | Enlarged kidneys (HP:0000105) | 2.11191762 |
| 116 | Purpura (HP:0000979) | 2.10358820 |
| 117 | Amyloidosis (HP:0011034) | 2.09982628 |
| 118 | Parakeratosis (HP:0001036) | 2.09055163 |
| 119 | Glycosuria (HP:0003076) | 2.08510251 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 2.08510251 |
| 121 | Potter facies (HP:0002009) | 2.07304911 |
| 122 | Facial shape deformation (HP:0011334) | 2.07304911 |
| 123 | Ketoacidosis (HP:0001993) | 2.06664438 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 2.06187560 |
| 125 | Hypotrichosis (HP:0001006) | 2.06137925 |
| 126 | Hyperphosphatemia (HP:0002905) | 2.05178673 |
| 127 | Thin bony cortex (HP:0002753) | 2.00719043 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97615627 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97416100 |
| 130 | Adrenal overactivity (HP:0002717) | 1.97174570 |
| 131 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.95910397 |
| 132 | Subcapsular cataract (HP:0000523) | 1.95431275 |
| 133 | Abdominal distention (HP:0003270) | 1.94818967 |
| 134 | Myocardial infarction (HP:0001658) | 1.94329811 |
| 135 | Autoimmune thrombocytopenia (HP:0001973) | 1.91393890 |
| 136 | Epidermoid cyst (HP:0200040) | 1.90926309 |
| 137 | Abnormality of potassium homeostasis (HP:0011042) | 1.90686927 |
| 138 | Abnormal hand bone ossification (HP:0010660) | 1.89947522 |
| 139 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89803427 |
| 140 | Rickets (HP:0002748) | 1.89211186 |
| 141 | Glomerulosclerosis (HP:0000096) | 1.88831106 |
| 142 | Autoimmune hemolytic anemia (HP:0001890) | 1.88349873 |
| 143 | Vacuolated lymphocytes (HP:0001922) | 1.87241207 |
| 144 | Distal lower limb muscle weakness (HP:0009053) | 1.87126428 |
| 145 | Hepatoblastoma (HP:0002884) | 1.86289565 |
| 146 | Mitral stenosis (HP:0001718) | 1.84904500 |
| 147 | Flat acetabular roof (HP:0003180) | 1.84643290 |
| 148 | Hyperglycinemia (HP:0002154) | 1.84614575 |
| 149 | Fragile skin (HP:0001030) | 1.83683349 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.83212298 |
| 151 | Hypohidrosis (HP:0000966) | 1.82827793 |
| 152 | Abnormal ossification of hand bones (HP:0005921) | 1.81595511 |
| 153 | Ureteral stenosis (HP:0000071) | 1.81478820 |
| 154 | Abnormal tarsal ossification (HP:0008369) | 1.79260181 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.79211159 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.78890330 |
| 157 | Alopecia of scalp (HP:0002293) | 1.77490082 |
| 158 | Vaginal fistula (HP:0004320) | 1.76662722 |
| 159 | Aplasia cutis congenita (HP:0001057) | 1.75931881 |
| 160 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.75878660 |
| 161 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75765267 |
| 162 | Ventricular tachycardia (HP:0004756) | 1.75450851 |
| 163 | Abnormal hemoglobin (HP:0011902) | 1.75003689 |
| 164 | Delayed epiphyseal ossification (HP:0002663) | 1.74442537 |
| 165 | Abnormality of the nasal septum (HP:0000419) | 1.72122967 |
| 166 | Metabolic acidosis (HP:0001942) | 1.71715425 |
| 167 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70817831 |
| 168 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70784705 |
| 169 | Metaphyseal irregularity (HP:0003025) | 1.70566829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 5.52435901 |
| 2 | ACVR1B | 5.17183301 |
| 3 | EPHA2 | 4.14766783 |
| 4 | WNK4 | 3.82078292 |
| 5 | FRK | 3.11708992 |
| 6 | MST1R | 3.08762414 |
| 7 | WNK3 | 2.96628965 |
| 8 | OXSR1 | 2.80956276 |
| 9 | STK39 | 2.39324976 |
| 10 | FER | 2.32633283 |
| 11 | MAP3K2 | 2.30129288 |
| 12 | EPHB1 | 2.27936942 |
| 13 | PTK6 | 2.19927877 |
| 14 | AKT3 | 2.10909483 |
| 15 | ICK | 2.06690181 |
| 16 | ERN1 | 2.02183932 |
| 17 | LATS1 | 2.00779586 |
| 18 | MAPKAPK3 | 2.00318845 |
| 19 | SIK1 | 1.81405994 |
| 20 | LRRK2 | 1.78746279 |
| 21 | MAP3K3 | 1.64744714 |
| 22 | MATK | 1.64345323 |
| 23 | EPHA3 | 1.61669960 |
| 24 | NME1 | 1.60221205 |
| 25 | EPHB2 | 1.58546791 |
| 26 | FGFR4 | 1.55308070 |
| 27 | TYRO3 | 1.53928581 |
| 28 | EEF2K | 1.53405424 |
| 29 | STK10 | 1.51899194 |
| 30 | CDK12 | 1.45255745 |
| 31 | PDPK1 | 1.43849833 |
| 32 | RPS6KB2 | 1.43175373 |
| 33 | LMTK2 | 1.42699388 |
| 34 | MAP3K10 | 1.37212708 |
| 35 | EPHA4 | 1.37119724 |
| 36 | MAP3K7 | 1.37114463 |
| 37 | MAPK11 | 1.29267042 |
| 38 | GRK6 | 1.24138619 |
| 39 | RIPK1 | 1.20827565 |
| 40 | PTK2 | 1.19867145 |
| 41 | MAP2K2 | 1.19337631 |
| 42 | CDC42BPA | 1.18174262 |
| 43 | FGFR2 | 1.15875559 |
| 44 | MAP3K14 | 1.15164935 |
| 45 | TESK2 | 1.13161213 |
| 46 | PDK1 | 1.11254726 |
| 47 | TRPM7 | 1.10831842 |
| 48 | DYRK1B | 1.09126328 |
| 49 | ERBB2 | 1.08461582 |
| 50 | TESK1 | 1.01618013 |
| 51 | MAPK15 | 0.99925202 |
| 52 | IRAK3 | 0.91014887 |
| 53 | NLK | 0.87959308 |
| 54 | PRKACG | 0.82355378 |
| 55 | PKN2 | 0.80064116 |
| 56 | CSF1R | 0.79433944 |
| 57 | PRKCI | 0.78787395 |
| 58 | ITK | 0.78128516 |
| 59 | TNK2 | 0.78055743 |
| 60 | FGR | 0.77638789 |
| 61 | ERBB3 | 0.75889373 |
| 62 | CDK6 | 0.75517818 |
| 63 | STK38L | 0.74276510 |
| 64 | MET | 0.73449645 |
| 65 | TYK2 | 0.73233903 |
| 66 | MAP3K11 | 0.71259614 |
| 67 | PIK3CA | 0.70536734 |
| 68 | FGFR3 | 0.69946276 |
| 69 | PRKCZ | 0.68055692 |
| 70 | PDGFRB | 0.67619346 |
| 71 | MAP4K1 | 0.67334923 |
| 72 | NUAK1 | 0.65947257 |
| 73 | BMX | 0.64288873 |
| 74 | WNK1 | 0.63119317 |
| 75 | KSR2 | 0.62853379 |
| 76 | TNIK | 0.61101189 |
| 77 | PRKG2 | 0.60966495 |
| 78 | BTK | 0.60074712 |
| 79 | CHUK | 0.58358553 |
| 80 | TBK1 | 0.57654458 |
| 81 | MAP3K1 | 0.56280269 |
| 82 | SGK494 | 0.54880040 |
| 83 | SGK223 | 0.54880040 |
| 84 | MAP3K12 | 0.54257919 |
| 85 | PIK3CG | 0.52640104 |
| 86 | TGFBR2 | 0.52531690 |
| 87 | RPS6KA1 | 0.51660337 |
| 88 | HIPK2 | 0.50963777 |
| 89 | PAK4 | 0.50241645 |
| 90 | STK3 | 0.49860406 |
| 91 | PAK3 | 0.49243688 |
| 92 | YES1 | 0.48985210 |
| 93 | MAPKAPK5 | 0.48515550 |
| 94 | TRIB3 | 0.48107679 |
| 95 | MAP2K6 | 0.47705876 |
| 96 | NME2 | 0.46779190 |
| 97 | JAK2 | 0.46479362 |
| 98 | PDK2 | 0.44709343 |
| 99 | IKBKE | 0.44655577 |
| 100 | FYN | 0.42953176 |
| 101 | JAK1 | 0.42569431 |
| 102 | STK38 | 0.42119978 |
| 103 | MYLK | 0.41911161 |
| 104 | IGF1R | 0.39461559 |
| 105 | JAK3 | 0.39118726 |
| 106 | DYRK3 | 0.38914179 |
| 107 | RET | 0.38051956 |
| 108 | SGK1 | 0.37687233 |
| 109 | PRKAA1 | 0.36495305 |
| 110 | MAPKAPK2 | 0.36261155 |
| 111 | ZAP70 | 0.36222088 |
| 112 | SMG1 | 0.35555758 |
| 113 | SRC | 0.34917189 |
| 114 | PRKCA | 0.34481764 |
| 115 | FGFR1 | 0.33255793 |
| 116 | MAP2K1 | 0.33172413 |
| 117 | PDGFRA | 0.33062694 |
| 118 | SCYL2 | 0.32648876 |
| 119 | DDR2 | 0.32587215 |
| 120 | PRKG1 | 0.32057958 |
| 121 | PDK4 | 0.31304249 |
| 122 | PDK3 | 0.31304249 |
| 123 | BRD4 | 0.30912575 |
| 124 | NEK6 | 0.30643197 |
| 125 | BCR | 0.30640617 |
| 126 | RIPK4 | 0.30472017 |
| 127 | GSK3A | 0.29507939 |
| 128 | PIM2 | 0.29408436 |
| 129 | TAOK3 | 0.28659543 |
| 130 | MAP3K8 | 0.28549006 |
| 131 | MELK | 0.28436103 |
| 132 | IRAK1 | 0.28210745 |
| 133 | TAOK1 | 0.27760214 |
| 134 | TGFBR1 | 0.27684295 |
| 135 | CSK | 0.27246637 |
| 136 | SGK3 | 0.26849206 |
| 137 | NEK9 | 0.26708363 |
| 138 | PRKAA2 | 0.25271343 |
| 139 | RPS6KB1 | 0.24134298 |
| 140 | INSRR | 0.23698076 |
| 141 | STK24 | 0.23274947 |
| 142 | CDK7 | 0.22573090 |
| 143 | LCK | 0.21430540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.25815235 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.99443467 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 2.94295773 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69925179 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39852812 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.39773505 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.33775785 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.32470706 |
| 9 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.28948675 |
| 10 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.07816129 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99367848 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97238808 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.94298502 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92502494 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87564789 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79375493 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.75802103 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72734671 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.68371946 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67985465 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.64155629 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60563944 |
| 23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.59552947 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52071663 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46295193 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43995245 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.43837875 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41551507 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.39741389 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.39592411 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36824180 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36079266 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35572216 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.33479853 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26257722 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22798246 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19777154 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17538985 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.14905837 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.13800820 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.13443984 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11472552 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11386247 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10280594 |
| 45 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.10176726 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09524932 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06722228 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05880095 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04572988 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02569445 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02290307 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99378429 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98007480 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93588159 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88143133 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87451504 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86479271 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.85377156 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85202832 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84269523 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80925359 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78706036 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76713807 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.75276340 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74604649 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73488872 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.72552031 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70470950 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69904913 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68368835 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66308826 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66067514 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65882908 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64819856 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.63551254 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.63120856 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62784893 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62401519 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59696807 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58901154 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57018501 |
| 82 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56673467 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56509028 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55299812 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55280969 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.54387036 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54278277 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53636610 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52339829 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51591226 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50147202 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.49879288 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47693613 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47640211 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46293099 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46241230 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45925193 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45272323 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44710234 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.43887363 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43857282 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43536830 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.42044556 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42020370 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40029761 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39924573 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.38623073 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38600430 |
| 109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38590456 |
| 110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38518085 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38423966 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36036949 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35702207 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34114241 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33826941 |
| 116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33748998 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33267491 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.31411853 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29494357 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26823449 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24511342 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22682202 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15892890 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.14779074 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13243427 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11535145 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.09974789 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.09785359 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07934857 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.01822043 |
| 131 | Allograft rejection_Homo sapiens_hsa05330 | 0.00517148 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0645006 |
| 133 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0486793 |
| 134 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0462353 |
| 135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.0093325 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0073353 |

